Bezafibrate therapy in primary biliary cholangitis refractory to ursodeoxycholic acid: a longitudinal study of paired liver biopsies at 5 years of follow up-Reference-Cited by-同舟云学术

Bezafibrate therapy in primary biliary cholangitis refractory to ursodeoxycholic acid: a longitudinal study of paired liver biopsies at 5 years of follow up

Published:2021-09-29 Issue:9 Volume:54 Page:1202-1212
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Sorda Juan Antonio¹,González Ballerga Esteban¹,Barreyro Fernando Javier²^ORCID,Avagnina Alejandra³,Carballo Pilar³,Paes de Lima Andrea³,Daruich Jorge¹

Affiliation:

1. Department of Gastroenterology and Hepatology University Hospital “José de San Martín” Faculty of Medicine University of Buenos Aires Buenos Aires Argentina

2. Biotechnology Institute of Misiones (INBIOMIS) National University of MisionesNational Scientific and Technical Research Council (CONICET) Posadas Argentina

3. Department of Pathology University Hospital “José de San Martín” Faculty of Medicine University of Buenos Aires Buenos Aires Argentina

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16618

Reference53 articles.

1. Primary biliary cirrhosis

2. Natural history of primary biliary cirrhosis

3. Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid

4. Primary biliary cirrhosis

5. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PPAR agonists in PBC: Where do we go from here? Or how to choose between the new and the old;Clinics and Research in Hepatology and Gastroenterology;2024-06

2. Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid;European Journal of Internal Medicine;2024-06

3. Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis;Alimentary Pharmacology & Therapeutics;2024-02-26

4. Research Progress in the Treatment of Primary Biliary Cholangitis with Chinese and Western Medicine;Traditional Chinese Medicine;2024

5. The role of peroxisome proliferator‐activated receptors in the regulation of bile acid metabolism;Basic & Clinical Pharmacology & Toxicology;2023-12-15